Download PDF
Semin Liver Dis 2012; 32(03): 220-227
DOI: 10.1055/s-0032-1323627
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hepatitis Delta Virus Diagnosis

Antonella Olivero
1   Laboratory of Digestive and Liver Physiopathology, Department of Gastroenterology and Hepatology, “San Giovanni Battista” Hospital, Torino, Italy
2   Department of Internal Medicine, University of Turin, Torino, Italy
,
Antonina Smedile
1   Laboratory of Digestive and Liver Physiopathology, Department of Gastroenterology and Hepatology, “San Giovanni Battista” Hospital, Torino, Italy
2   Department of Internal Medicine, University of Turin, Torino, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
29 August 2012 (online)

    Permissions and Reprints

Abstract

The first step in the diagnosis of hepatitis delta virus (HDV) infection is testing HBsAg-positive individuals for the antibody to the HD antigen (anti-HD).

In anti-HD-positive patients, the next step is testing for HDV RNA in serum to determine whether the antibody reflects an ongoing active HDV infection (HDV-RNA-positive) or represents a serologic scar to past HDV infection (HDV-RNA-negative). In the HDV-positive individual with liver disease, it is critical to distinguish acute HDV/hepatitis B virus (HBV) coinfection from chronic HDV superinfection in HBsAg carriers; the course, prognosis, and management of the two conditions are different. The differential diagnosis can be achieved through the scrutiny of the battery of HDV and HBV markers, which combine in patterns characteristic for each condition.

Standardized competitive and μ-capture commercial assays are available to determine the IgG and IgM antibody to HDV. Several in-house assays were developed to determine HDV RNA in serum; the sensitivity threshold of current polymerase chain reaction-based assays is 10 copies of HDV RNA/mL. Unfortunately, HDV-RNA assays are not yet standardized and the results from different laboratories often are not comparable due to different sensitivities. The development of an international reference HDV-RNA standard remains an unmet diagnostic need.

Keywords

HDV - HDV-RNA - anti-HD IgG - anti-HDIgM - RT-PCR - CHD
 

  • References

  • 1 Rizzetto M. Hepatitis D: thirty years after. J Hepatol 2009; 50 (5) 1043-1050
    CrossrefPubMedGoogle Scholar
  • 2 Smedile A, Rizzetto M, Gerin JL. Advances in hepatitis D virus biology and disease. In: Boyer JL, Ockner RK, , eds. Progress in Liver Disease. Vol. XII. Philadelphia, PA: WB Saunders; 1994: 157-175
    Google Scholar
  • 3 Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010; 7 (1) 31-40
    CrossrefPubMedGoogle Scholar
  • 4 Farci P. Delta hepatitis: an update. J Hepatol 2003; 39 (Suppl. 01) S212-S219 Review
    CrossrefPubMedGoogle Scholar
  • 5 Caredda F, Antinori S, Re T, Pastecchia C, Moroni M. Course and prognosis of acute HDV hepatitis. Prog Clin Biol Res 1987; 234: 267-276
    PubMedGoogle Scholar
  • 6 Caredda F, Antinori S, Pastecchia C , et al. Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis 1989; 159 (5) 977-979
    CrossrefPubMedGoogle Scholar
  • 7 Moestrup T, Hansson BG, Widell A, Nordenfelt E. Clinical aspects of delta infection. Br Med J (Clin Res Ed) 1983; 286 (6359) 87-90
    CrossrefPubMedGoogle Scholar
  • 8 Deterding K, Pothakamuri SV, Schlaphoff V , et al. Clearance of chronic HCV infection during acute delta hepatitis. Infection 2009; 37 (2) 159-162
    CrossrefPubMedGoogle Scholar
  • 9 De Cock KM, Govindarajan S, Valinluck B, Redeker AG. Hepatitis B virus DNA in fulminant hepatitis B. Ann Intern Med 1986; 105 (4) 546-547
    CrossrefPubMedGoogle Scholar
  • 10 Govindarajan S, Valinluck B, Peters L. Relapse of acute B viral hepatitis—role of delta agent. Gut 1986; 27 (1) 19-22
    CrossrefPubMedGoogle Scholar
  • 11 Rizzetto M, Ponzetto A, Bonino F, Smedile A. Hepatitis delta virus infection: clinical and epidemiological aspects. In: Zuckerman AJ, , ed. Viral Hepatitis and Liver Disease. New York: Alan R. Liss; 1988: 389-394
    Google Scholar
  • 12 Negro F, Rizzetto M. Diagnosis of hepatitis delta virus infection. J Hepatol 1995; 22 (1, Suppl) 136-139
    PubMedGoogle Scholar
  • 13 Wedemeyer H, Yurdaydìn C, Dalekos GN , et al; HIDIT Study Group. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011; 364 (4) 322-331
    CrossrefPubMedGoogle Scholar
  • 14 Olivero A, Fontana R, Niro GA , et al. Kinetics of HDV-RNA and hepatitis B surface antigen in chronic delta hepatitis under pegylated interferon and/or nucleoside analogs therapy. Hepatology 2011; 54 (suppl. 4) Abstract 1508; 1077A
    PubMedGoogle Scholar
  • 15 Roingeard P, Dubois F, Marcellin P , et al. Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection. J Med Virol 1992; 38 (3) 191-194
    CrossrefPubMedGoogle Scholar
  • 16 Moestrup T, Hansson BG, Widell A, Nordenfelt E, Hägerstrand I. Long term follow up of chronic hepatitis B virus infection in intravenous drug abusers and homosexual men. Br Med J (Clin Res Ed) 1986; 292 (6524) 854-857
    CrossrefPubMedGoogle Scholar
  • 17 Niro GA, Gravinese E, Martini E , et al. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. Liver 2001; 21 (4) 254-259
    PubMedGoogle Scholar
  • 18 Smedile A, Lavarini C, Crivelli O, Raimondo G, Fassone M, Rizzetto M. Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen: clinical significance in delta infection. J Med Virol 1982; 9 (2) 131-138
    CrossrefPubMedGoogle Scholar
  • 19 Borghesio E, Rosina F, Smedile A , et al. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation. Hepatology 1998; 27 (3) 873-876
    CrossrefPubMedGoogle Scholar
  • 20 Poggio PD, Colombo S, Zaccanelli M, Rosti A. Immunoglobulin M anti-hepatitis D virus in monitoring chronic hepatitis delta. Liver Int 2011; 31 (10) 1598 10.1111/j.1478-3231.2011.02518.x
    PubMedGoogle Scholar
  • 21 Mederacke I, Yurdaydin C, Dalekos GN , et al; Hep-Net/International Delta Hepatitis Study Group. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment. Antivir Ther 2012; 17 (2) 305-312 10.3851/IMP1926
    PubMedGoogle Scholar
  • 22 Niro GA, Ciancio A, Gaeta GB , et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 2006; 44 (3) 713-720
    CrossrefPubMedGoogle Scholar
  • 23 Pascarella S, Negro F. Hepatitis D virus: an update. Liver Int 2011; 31 (1) 7-21 10.1111/j.1478-3231.2010.02320.x
    CrossrefPubMedGoogle Scholar
  • 24 Novick DM, Farci P, Croxson TS , et al. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 1988; 158 (4) 795-803
    CrossrefPubMedGoogle Scholar
  • 25 Smedile A, Rizzetto M, Denniston K , et al. Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay. Hepatology 1986; 6 (6) 1297-1302
    CrossrefPubMedGoogle Scholar
  • 26 Smedile A, Niro MG, Rizzetto M. Detection of serum HDV-RNA by RT-PCR. In: Hamatake RK, Lau JYN, , eds. Methods in Molecular Medicine. Totowa, NJ: Humana Press; 2004: 85-93
    Google Scholar
  • 27 Yamashiro T, Nagayama K, Enomoto N , et al. Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction—and its possible correlation with the clinical stage of liver disease. J Infect Dis 2004; 189 (7) 1151-1157
    CrossrefPubMedGoogle Scholar
  • 28 Le Gal F, Gordien E, Affolabi D , et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 2005; 43 (5) 2363-2369
    CrossrefPubMedGoogle Scholar
  • 29 Hofmann J, Frenzel K, Minh BQ , et al. Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis. Diagn Microbiol Infect Dis 2010; 67 (2) 172-179
    CrossrefPubMedGoogle Scholar
  • 30 Mederake I, Brenner B, Heidrich B , et al. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the COBAS TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 2010; 48 (6) 2022-2029
    CrossrefPubMedGoogle Scholar
  • 31 Pollicino T, Raffa G, Santantonio T , et al. Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. J Virol 2011; 85 (1) 432-439
    CrossrefPubMedGoogle Scholar
  • 32 Dény P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?. Curr Top Microbiol Immunol 2006; 307: 151-171
    PubMedGoogle Scholar
  • 33 Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 1997; 25 (3) 728-734
    CrossrefPubMedGoogle Scholar
  • 34 Radjef N, Gordien E, Ivaniushina V , et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004; 78 (5) 2537-2544
    CrossrefPubMedGoogle Scholar
  • 35 Casey JL, Niro GA, Engle RE , et al. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis 1996; 174 (5) 920-926
    CrossrefPubMedGoogle Scholar
  • 36 Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat 2009; 16 (12) 883-894
    CrossrefPubMedGoogle Scholar
  • 37 Soriano V, Grint D, d'Arminio Monforte A , et al. Hepatitis delta in HIV-infected individuals in Europe. AIDS 2011; 25 (16) 1987-1992
    CrossrefPubMedGoogle Scholar
  • 38 Raimondo G, Brunetto MR, Pontisso P , et al; Associazione Italiana Studio Fegato Cooperative Group. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 2006; 43 (1) 100-107
    CrossrefPubMedGoogle Scholar
  • 39 Schaper M, Rodriguez-Frias F, Jardi R , et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol 2010; 52 (5) 658-664
    CrossrefPubMedGoogle Scholar